Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.prevetmed.2020.104944 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapy.
World J Gastrointest Oncol
October 2024
Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433, Singapore.
In this editorial, I comment on three articles published in the recent issue of the . Hepatocellular carcinoma (HCC) is an important public health concern, and there are three articles on the theme of HCC in this issue. I focus on the articles by Mu , Chu , and Ma for this editorial.
View Article and Find Full Text PDFComment on Dutta Majumder et al.'s 2019 'Ocular Syphilis: An Update'.
Ocul Immunol Inflamm
October 2024
Papworth Hospital, Cambridge University Hospital, Cambridge, UK.
The article provides a thorough review of the challenges in diagnosing ocular syphilis. However, our research on 'Dermatological and Ocular Manifestations of Syphilis,' identifies a significant gap in both literature and clinical practice: the lack of recognition of dermatological signs during ophthalmological assessments. Ocular syphilis often mimics other conditions and can remain undiagnosed for months or years.
View Article and Find Full Text PDFAdvances in understanding and managing celiac disease: Pathophysiology and treatment strategies.
World J Gastroenterol
September 2024
Department of Burns, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui Province, China.
Article Synopsis
- The editorial discusses celiac disease (CeD), an autoimmune condition primarily affecting individuals with a genetic predisposition, characterized by gluten intolerance and symptoms like abdominal pain and diarrhea.* -
- Patients with CeD must adhere to a lifelong gluten-free diet, which can significantly impact their quality of life and financial well-being.* -
- The piece highlights the challenges in finding effective treatments due to the complex nature of CeD's pathogenesis and reviews both the disease's mechanisms and the current state of experimental and improved drug options.*
Discovery of new antigens for serodiagnosis of visceral leishmaniasis in humans and dogs adds valuable tools to our arsenal.
mBio
August 2024
Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Surveillance and sustained control of visceral leishmaniasis (VL) require reliable serodiagnostic tools. rK39, the gold standard antigen for VL diagnosis, is limited by its documented poor sensitivity in certain endemic regions, such as East Africa, and by the longevity of its antibodies, making it difficult to distinguish active from cured infections. In a recent publication in , Roberts et al.
View Article and Find Full Text PDFReply to: Serological response after COVID-19 vaccination, cirrhosis, and postliver transplant.
Hepatol Commun
June 2024
Liver Failure Group, Institute for Liver and Digestive Health, University College London, Royal Free Campus, London, UK.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!